Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Combination of Q-switched 1,064 and 532 nm Nd: YAG laser in the treatment of toenail onychomycosis: a pilot study

The dual-wavelength Q-switched Nd: YAG laser appears to be a promising treatment option for mild onychomycosis, although its effectiveness is limited in severe onychomycosis.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a pilot trial of 15 participants with toenail onychomycosis treated weekly for eight weeks with a dual-wavelength Q-switched Nd:YAG laser (1,064 nm and 532 nm). At week 43, 33.3% (5 of 15) achieved mycological and complete cure. The authors describe the laser as a promising option for mild onychomycosis, with effectiveness limited in severe cases.

Participants
15
Who or what was studied
Adults with distal lateral subungual onychomycosis of the big toe caused by dermatophytes
Wavelengths
532 nm
Limits stated in the abstract
The abstract describes a small pilot study, so the findings are preliminary and need further research.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Previous studies have demonstrated that laser-based therapies can effectively improve the appearance of nails affected by onychomycosis, offering a high safety margin, making them suitable for patients in whom systemic antifungal agents are contraindicated. Building on earlier studies, a pilot clinical trial was designed to assess the effectiveness of a Q-switched Nd: YAG laser using dual wavelengths (1,064 nm and 532 nm) for the treatment of toenail onychomycosis. This study involved 15 participants with distal lateral subungual onychomycosis (DLSO) of the big toe caused by dermatophytes. Each laser session included two applications of 1,064 Nd: YAG laser at 600 mJ/pulse, 20 ns, 2 Hz, for 1 min, separated by a 1-minute pause. After a 2-minute rest, the 532 nm laser was applied in a similar manner using the same parameters. Treatments were administered weekly over eight weeks. Progress was monitored using the Onychomycosis Severity Index (OSI), based on direct clinical examination and photographs taken at baseline, during each session, and at follow-up visits. Mycological clearance was assessed via PAS-stained histopathology and fungal culture. Pain during treatment was evaluated using a visual analogue scale (VAS), and any side effects were recorded. At week 43, both mycological cure rate (MCR) and complete cure rate (CCR) were 33.3% (5 out 15 patients). The laser therapy was well-tolerated, with no reported adverse effects. Pain scores averaged 6.5 ± 0.5 during the 1,064 nm application and 7.8 ± 0.5 during the 532 nm application. Despite some discomfort, patient satisfaction remained high. The dual-wavelength Q-switched Nd: YAG laser appears to be a promising treatment option for mild onychomycosis, although its effectiveness is limited in severe onychomycosis. Further research is needed to optimize laser parameters, session frequency, and follow-up duration to maximize therapeutic outcomes.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
532 nm, 064 nm

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Laser, Pilot study, Visual analogue scale, Wavelength. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies